Innopharma Technology is a pioneering force in the industry 4.0 landscape, specializing in delivering cutting-edge technology solutions tailored to the pharmaceutical development and manufacturing sector. With a firm commitment to enhancing manufacturing process comprehension, elevating quality adherence, and ultimately bolstering patient safety and efficacy, Innopharma Technology is at the forefront of revolutionizing the future of manufacturing. The company's remarkable achievements include securing the prestigious Irish Times Innovation of the Year Award in 2018 and being backed by the EU Horizon 2020 initiative.
Boasting a dynamic team comprising accomplished hardware and software engineers and scientists, Innopharma Technology boasts a proven track record in Process Analytical Technology (PAT) business. The company specializes in leveraging advanced control and automation principles while ensuring the secure democratization of data. Through a steadfast focus on the ongoing advancement of PAT and a diverse array of industrial applications, Innopharma Technology remains dedicated to spearheading the development and commercialization of a Smart control & automation technology suite.
Founded in 2009 and headquartered in Ireland, Innopharma Technology presents an enticing prospect for investors looking to support ventures at the cutting edge of analytics, automation, and pharmaceutical innovation.